Olympus Announces Launch Of Single-Use Hemostasis Clip

The RetentiaTM HemoClip offers the following benefits:

• Arm lengths of 9mm, 12mm, and 16mm to accommodate a variety of closure applications¹
• A short tail length which helps with visualization of the target site, potentially facilitating the placement of multiple clips compared to long tail lengths¹
• Sheath markings that are designed to aid in insertion and extraction¹
• An intuitive handle design which enables the clip to be deployed in a single step¹.

Performing hemostasis within the GI tract is a technically demanding procedure and use of hemostatic clips and associated devices may result in patient injury including but not limited to inflammatory reaction, infection, bleeding and perforation.

"The RetentiaTM HemoClip is another example of Olympus' commitment to understanding the needs of clinicians and addressing them, and for this reason among others, we are excited to bring this solution to the market," said Mike Callaghan, Global VP and General Manager for EndoTherapy, Olympus Corp. of the Americas. "As procedural needs within GI endoscopy continue to evolve, so too must our solutions. Features like ease in deployment and a broad range of size options have become imperative for procedure success, and we're proud to deliver on these improvements for GI endoscopists."

The RetentiaTM HemoClip is part of a comprehensive Olympus EndoTherapy portfolio that provides physicians with advanced solutions for procedures such as endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD).

EMR and ESD² are techniques for removing cancerous or other abnormal tissues from the digestive tract. Olympus' endoscopic portfolio includes devices such as electrosurgical knives, and hemostatic forceps that provide targeted monopolar coagulation. The portfolio also includes technology to help detect and control gastrointestinal bleeding in combination with conventional techniques such as clips.

Hemostasis is an important concern for GI physicians, and the RetentiaTM HemoClip reflects Olympus' continued focus on solving the challenge of bleeding during endoscopic procedures. Olympus' Red Dichromatic Imaging (RDITM) technology, a feature of the EVIS X1TM endoscopy system, helps improve the visibility of bleeding points within the mucosa and enhances the visibility of deep blood vessels compared to white light.³ RDITM technology is not intended to replace histopathological sampling as a means of diagnosis. In addition, EndoClot® Polysaccharide Hemostatic Spray (PHS) is a powder hemostat indicated for use, in combination with other conventional techniques like clips, to control bleeds.

Visit the gastroenterology or hemostasis product pages for more information about the entire Olympus GI portfolio.

About Olympus
As a leading medical technology company, Olympus uses medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures with the goal of improving clinical outcomes, reducing overall costs, and enhancing the quality of life for patients. Olympus' Medical portfolio includes, but is not limited to, endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of EndoTherapy devices. For more information, visit href="" rel="nofollow" olympusameric .

¹ Data on File with Yangzhou Fartley Medical Instrument Technology Co., Ltd.
² ESD is technically demanding, and improper use may result in patient injury, bleeding and/or perforation.
³ Data on file with Olympus (D00489968)

SOURCE Olympus Corporation of the Americas

MENAFN04032025003732001241ID1109275751